David W AndrewsMaged GoubranAvril MansfieldWalter SwardfagerBradley MacintoshJustin KaleEmmanuel ChérinMichele K. AndersonMark I BoulosPatrick M BrauerAbby LiJohanna SanchezGord MawdsleyJames G MainprizeDavid KreindlerLaura M VecchioTaku HibinoChristianne HoeyClement HamaniC SchuurmansRyan T MuirDang NguyenMardie SerenityR I AvivDiego LlovetJessica WiddifieldJoAnne McLaurinAnne L MartelSara McEwenI AubertStephanie R CiminoA Y Ma
P108
Study of Zevalin Versus Observation in Patients at Least 60 Yrs Old With Newly Diagnosed Diffuse Large B-cell Lymphoma in PET-negative Complete Remission After R-CHOP or R-CHOP-like TherapyIpatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer
P6153
Q37838821-04722E51-9328-425D-B942-F2F7827FA9D5Q39185179-C7F737F2-5346-4B5D-B4B8-0E57F29E0924Q41671527-24306BA4-9174-4D51-B5F2-BE793FA06EB7Q42173750-C381892E-A2FE-4ECB-91CB-62691E052AD7Q42892735-58C465D3-A477-41C9-BBA2-3A6C29857D9DQ47155592-BA21D3DE-EC2F-4446-83C3-76B81AA48465Q47833549-E3C982EC-BB91-4F5D-A4A3-A9386BF685C0Q50669391-FABA8B32-2A05-4E06-BF89-CB02AF10D125Q57143480-F1221A61-AF99-49D4-BD04-A14E226FEE3DQ58210632-04D9026A-12F8-46CA-A9E8-F1E792F1B47DQ58326482-6BF49398-A5FA-4834-8C25-7AEE5BDECB5FQ59199628-3661A4B1-E8E6-450F-8465-143FFEDB6EDBQ59392357-D083BD5B-DB35-48F1-BCAA-929103AAF1F0Q60664492-271D4EBF-0D46-418E-AA0C-6E91A19964C1Q60956731-6146C6B6-6CF3-4870-8A88-10121BC63402Q61799622-D632A6C5-E5A9-4C18-BB2E-5E0072E85AA1Q63696171-A4109853-CA12-42F5-B2FA-19228F3B8DABQ64684509-B9BB3213-81E3-445D-A421-EDC05CDC5451Q64787059-3A1084F3-8A9B-48FC-8473-BBA4C4C1F005Q73588413-19A016DC-E3EF-4FBD-BBA8-23A2650C90FDQ86185307-11B1D376-BF03-4135-AF61-408F947F11E1Q86829084-760149AA-1A06-4A07-B51A-8B3FFD7CC63CQ86850408-0C185C14-56A0-45DC-96C3-A818D8FBDDC1Q86850408-1185F0E7-98F0-4B7F-AE9B-1109805C3840Q87687031-16FBAA7F-081C-442D-8848-70F0AFBF50D6Q87809588-9824D74C-4427-4084-8757-39A94EA54093Q87985652-EF2E2755-EBE8-4887-9524-67983096AF37Q88553841-E0BEC87A-2821-4923-A4E7-8B427230F133Q88608925-B44230A7-147A-4D46-950F-8B25DACB217FQ89431881-951E9D1F-468E-4C07-B375-81901DDE03C5Q89498299-398533BD-EF0D-4EB1-806E-013B2D8DEBE2Q89527419-2365A291-0434-4444-B26E-D3F608FD251AQ89811563-707C7E02-314C-4CB2-A6BC-CA64841E4705
P108
description
Forschungseinrichtung in Kanada
@de
the research component of Sunnybrook Health Sciences Centre in Toronto, Canada
@en
name
Sunnybrook Research Institute
@en
type
label
Sunnybrook Research Institute
@en
prefLabel
Sunnybrook Research Institute
@en
P6366
P646
P159
P17
P213
0000 0004 0469 1398
P3417
Sunnybrook-Research-Institute
P3500
P6366
P646
/m/05p48_r